Review



transwell inserts  (CELLTREAT Scientific)


Bioz Verified Symbol CELLTREAT Scientific is a verified supplier
Bioz Manufacturer Symbol CELLTREAT Scientific manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    CELLTREAT Scientific transwell inserts
    Transwell Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/transwell inserts/product/CELLTREAT Scientific
    Average 93 stars, based on 9 article reviews
    transwell inserts - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    CELLTREAT Scientific transwell inserts
    Transwell Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/transwell inserts/product/CELLTREAT Scientific
    Average 93 stars, based on 1 article reviews
    transwell inserts - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    94
    CELLTREAT Scientific inserts
    Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inserts/product/CELLTREAT Scientific
    Average 94 stars, based on 1 article reviews
    inserts - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    CELLTREAT Scientific cell culture inserts
    Cell Culture Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell culture inserts/product/CELLTREAT Scientific
    Average 94 stars, based on 1 article reviews
    cell culture inserts - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    CELLTREAT Scientific pore size
    Pore Size, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pore size/product/CELLTREAT Scientific
    Average 94 stars, based on 1 article reviews
    pore size - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    99
    CELLTREAT Scientific porous polycarbonate membrane
    Porous Polycarbonate Membrane, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/porous polycarbonate membrane/product/CELLTREAT Scientific
    Average 99 stars, based on 1 article reviews
    porous polycarbonate membrane - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Corning Life Sciences 24-well permeable cell culture inserts
    (A) Endothelial permeability assay: Confluent monolayers of bEnd.3 brain endothelial cells cultured on Transwell <t>inserts</t> were treated with isoDGR-peptide (50 μg/mL) or vehicle control. Permeability to 60-70 kDa FITC-dextran was measured in the lower chamber at indicated time points. IsoDGR significantly increased paracellular tracer flux, indicating compromised barrier integrity (n = 6 wells per group). Fluorescence was quantified using a fluorometer, and statistical analysis was performed using repeated measures ANOVA. (B) Scratch-wound motility assay: bEnd.3 monolayers were scratched with a pipette tip and cultured in the presence or absence of isoDGR-peptide (50 μg/mL). Wound width was imaged and measured up to 48 hours. IsoDGR treatment significantly delayed wound closure, demonstrating impaired endothelial <t>cell</t> migration (n = 6). Statistical analysis: one-way repeated measures ANOVA. (C) Representative brightfield images of scratched bEnd.3 <t>cultures</t> at 24 hours post-injury. Untreated control cells exhibit narrower wound gaps, whereas isoDGR-treated cells show substantially delayed closure. Red scale bars and yellow outlines demarcate wound width (μm). (D) Integrin αV immunostaining: bEnd.3 cells treated 24 hours with isoDGR-peptide (50 μg/mL) or vehicle control were fixed and stained for Integrin αV (green) and DAPI (blue). Fluorescence imaging revealed enhanced integrin αV signal in isoDGR-treated cells. (E) Quantification of Integrin αV fluorescence intensity across image using Image J. IsoDGR significantly upregulated integrin αV expression (****p < 0.0001, unpaired t-test), suggesting possible involvement of integrin signaling. (F) Densitometric analysis of six independent blots, normalized to control. IsoDGR increases the expression of integrin αV and β3 proteins, consistent with the immunofluorescence results (mean ± SEM; *p < 0.05, unpaired t-test). Scale bars: 100 μm. Error bars represent SEM. These findings support a functional link between isoDGR exposure and endothelial dysfunction via increased permeability, reduced motility, and integrin-mediated signaling.
    24 Well Permeable Cell Culture Inserts, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/24-well permeable cell culture inserts/product/Corning Life Sciences
    Average 90 stars, based on 1 article reviews
    24-well permeable cell culture inserts - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    CELLTREAT Scientific transwell membranes
    (A) Endothelial permeability assay: Confluent monolayers of bEnd.3 brain endothelial cells cultured on Transwell <t>inserts</t> were treated with isoDGR-peptide (50 μg/mL) or vehicle control. Permeability to 60-70 kDa FITC-dextran was measured in the lower chamber at indicated time points. IsoDGR significantly increased paracellular tracer flux, indicating compromised barrier integrity (n = 6 wells per group). Fluorescence was quantified using a fluorometer, and statistical analysis was performed using repeated measures ANOVA. (B) Scratch-wound motility assay: bEnd.3 monolayers were scratched with a pipette tip and cultured in the presence or absence of isoDGR-peptide (50 μg/mL). Wound width was imaged and measured up to 48 hours. IsoDGR treatment significantly delayed wound closure, demonstrating impaired endothelial <t>cell</t> migration (n = 6). Statistical analysis: one-way repeated measures ANOVA. (C) Representative brightfield images of scratched bEnd.3 <t>cultures</t> at 24 hours post-injury. Untreated control cells exhibit narrower wound gaps, whereas isoDGR-treated cells show substantially delayed closure. Red scale bars and yellow outlines demarcate wound width (μm). (D) Integrin αV immunostaining: bEnd.3 cells treated 24 hours with isoDGR-peptide (50 μg/mL) or vehicle control were fixed and stained for Integrin αV (green) and DAPI (blue). Fluorescence imaging revealed enhanced integrin αV signal in isoDGR-treated cells. (E) Quantification of Integrin αV fluorescence intensity across image using Image J. IsoDGR significantly upregulated integrin αV expression (****p < 0.0001, unpaired t-test), suggesting possible involvement of integrin signaling. (F) Densitometric analysis of six independent blots, normalized to control. IsoDGR increases the expression of integrin αV and β3 proteins, consistent with the immunofluorescence results (mean ± SEM; *p < 0.05, unpaired t-test). Scale bars: 100 μm. Error bars represent SEM. These findings support a functional link between isoDGR exposure and endothelial dysfunction via increased permeability, reduced motility, and integrin-mediated signaling.
    Transwell Membranes, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/transwell membranes/product/CELLTREAT Scientific
    Average 94 stars, based on 1 article reviews
    transwell membranes - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    CELLTREAT Scientific transwell plate
    (A) Endothelial permeability assay: Confluent monolayers of bEnd.3 brain endothelial cells cultured on Transwell <t>inserts</t> were treated with isoDGR-peptide (50 μg/mL) or vehicle control. Permeability to 60-70 kDa FITC-dextran was measured in the lower chamber at indicated time points. IsoDGR significantly increased paracellular tracer flux, indicating compromised barrier integrity (n = 6 wells per group). Fluorescence was quantified using a fluorometer, and statistical analysis was performed using repeated measures ANOVA. (B) Scratch-wound motility assay: bEnd.3 monolayers were scratched with a pipette tip and cultured in the presence or absence of isoDGR-peptide (50 μg/mL). Wound width was imaged and measured up to 48 hours. IsoDGR treatment significantly delayed wound closure, demonstrating impaired endothelial <t>cell</t> migration (n = 6). Statistical analysis: one-way repeated measures ANOVA. (C) Representative brightfield images of scratched bEnd.3 <t>cultures</t> at 24 hours post-injury. Untreated control cells exhibit narrower wound gaps, whereas isoDGR-treated cells show substantially delayed closure. Red scale bars and yellow outlines demarcate wound width (μm). (D) Integrin αV immunostaining: bEnd.3 cells treated 24 hours with isoDGR-peptide (50 μg/mL) or vehicle control were fixed and stained for Integrin αV (green) and DAPI (blue). Fluorescence imaging revealed enhanced integrin αV signal in isoDGR-treated cells. (E) Quantification of Integrin αV fluorescence intensity across image using Image J. IsoDGR significantly upregulated integrin αV expression (****p < 0.0001, unpaired t-test), suggesting possible involvement of integrin signaling. (F) Densitometric analysis of six independent blots, normalized to control. IsoDGR increases the expression of integrin αV and β3 proteins, consistent with the immunofluorescence results (mean ± SEM; *p < 0.05, unpaired t-test). Scale bars: 100 μm. Error bars represent SEM. These findings support a functional link between isoDGR exposure and endothelial dysfunction via increased permeability, reduced motility, and integrin-mediated signaling.
    Transwell Plate, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/transwell plate/product/CELLTREAT Scientific
    Average 93 stars, based on 1 article reviews
    transwell plate - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Endothelial permeability assay: Confluent monolayers of bEnd.3 brain endothelial cells cultured on Transwell inserts were treated with isoDGR-peptide (50 μg/mL) or vehicle control. Permeability to 60-70 kDa FITC-dextran was measured in the lower chamber at indicated time points. IsoDGR significantly increased paracellular tracer flux, indicating compromised barrier integrity (n = 6 wells per group). Fluorescence was quantified using a fluorometer, and statistical analysis was performed using repeated measures ANOVA. (B) Scratch-wound motility assay: bEnd.3 monolayers were scratched with a pipette tip and cultured in the presence or absence of isoDGR-peptide (50 μg/mL). Wound width was imaged and measured up to 48 hours. IsoDGR treatment significantly delayed wound closure, demonstrating impaired endothelial cell migration (n = 6). Statistical analysis: one-way repeated measures ANOVA. (C) Representative brightfield images of scratched bEnd.3 cultures at 24 hours post-injury. Untreated control cells exhibit narrower wound gaps, whereas isoDGR-treated cells show substantially delayed closure. Red scale bars and yellow outlines demarcate wound width (μm). (D) Integrin αV immunostaining: bEnd.3 cells treated 24 hours with isoDGR-peptide (50 μg/mL) or vehicle control were fixed and stained for Integrin αV (green) and DAPI (blue). Fluorescence imaging revealed enhanced integrin αV signal in isoDGR-treated cells. (E) Quantification of Integrin αV fluorescence intensity across image using Image J. IsoDGR significantly upregulated integrin αV expression (****p < 0.0001, unpaired t-test), suggesting possible involvement of integrin signaling. (F) Densitometric analysis of six independent blots, normalized to control. IsoDGR increases the expression of integrin αV and β3 proteins, consistent with the immunofluorescence results (mean ± SEM; *p < 0.05, unpaired t-test). Scale bars: 100 μm. Error bars represent SEM. These findings support a functional link between isoDGR exposure and endothelial dysfunction via increased permeability, reduced motility, and integrin-mediated signaling.

    Journal: bioRxiv

    Article Title: IsoDGR-Induced Endothelial Cytoskeletal Disruption Drives Age-Related Blood-Brain Barrier Breakdown

    doi: 10.1101/2025.07.08.663800

    Figure Lengend Snippet: (A) Endothelial permeability assay: Confluent monolayers of bEnd.3 brain endothelial cells cultured on Transwell inserts were treated with isoDGR-peptide (50 μg/mL) or vehicle control. Permeability to 60-70 kDa FITC-dextran was measured in the lower chamber at indicated time points. IsoDGR significantly increased paracellular tracer flux, indicating compromised barrier integrity (n = 6 wells per group). Fluorescence was quantified using a fluorometer, and statistical analysis was performed using repeated measures ANOVA. (B) Scratch-wound motility assay: bEnd.3 monolayers were scratched with a pipette tip and cultured in the presence or absence of isoDGR-peptide (50 μg/mL). Wound width was imaged and measured up to 48 hours. IsoDGR treatment significantly delayed wound closure, demonstrating impaired endothelial cell migration (n = 6). Statistical analysis: one-way repeated measures ANOVA. (C) Representative brightfield images of scratched bEnd.3 cultures at 24 hours post-injury. Untreated control cells exhibit narrower wound gaps, whereas isoDGR-treated cells show substantially delayed closure. Red scale bars and yellow outlines demarcate wound width (μm). (D) Integrin αV immunostaining: bEnd.3 cells treated 24 hours with isoDGR-peptide (50 μg/mL) or vehicle control were fixed and stained for Integrin αV (green) and DAPI (blue). Fluorescence imaging revealed enhanced integrin αV signal in isoDGR-treated cells. (E) Quantification of Integrin αV fluorescence intensity across image using Image J. IsoDGR significantly upregulated integrin αV expression (****p < 0.0001, unpaired t-test), suggesting possible involvement of integrin signaling. (F) Densitometric analysis of six independent blots, normalized to control. IsoDGR increases the expression of integrin αV and β3 proteins, consistent with the immunofluorescence results (mean ± SEM; *p < 0.05, unpaired t-test). Scale bars: 100 μm. Error bars represent SEM. These findings support a functional link between isoDGR exposure and endothelial dysfunction via increased permeability, reduced motility, and integrin-mediated signaling.

    Article Snippet: Briefly, 24-well permeable cell culture inserts with a 0.4 μm pore size (Corning, or A1048301, ThermoFisher Scientific) were coated with rat tail type I collagen (A1048301, ThermoFisher Scientific).

    Techniques: Permeability, Cell Culture, Control, Fluorescence, Motility Assay, Transferring, Migration, Immunostaining, Staining, Imaging, Expressing, Immunofluorescence, Functional Assay